Research in applied sciences is becoming more and more popular in attracting funds especially in biological fields. Since no research lab can survive without grant support, they are gradually drifting towards applied biotechnology, nanotechnology, drug development studies and preclinical/clinical trials. Should science solely be dictated by the demand of the market or scientists should have greater responsibilities for significant basic contributions that could help progressing individual field towards a new horizon that could ultimately change the face of the subject, redefines explored areas and opens prospective new avenues.